Jiangsu Nhwa Pharmaceutical Co Ltd (002262) — Free Cash Flow Generation Index
Jiangsu Nhwa Pharmaceutical Co Ltd (002262) has a Free Cash Flow Generation Index of 0.81x as of September 2025. Free cash flow of CN¥344.88 Million represents 1% of operating cash flow (CN¥425.83 Million). See Jiangsu Nhwa Pharmaceutical Co Ltd working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Jiangsu Nhwa Pharmaceutical Co Ltd Free Cash Flow Generation Index (2005–2025)
Historical FCF Generation Index trend for Jiangsu Nhwa Pharmaceutical Co Ltd across 21 annual periods. Explore Jiangsu Nhwa Pharmaceutical Co Ltd cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for Jiangsu Nhwa Pharmaceutical Co Ltd (2005–2025)
Year-by-year Free Cash Flow Generation Index for Jiangsu Nhwa Pharmaceutical Co Ltd. For the full company profile including market capitalisation, see Jiangsu Nhwa Pharmaceutical Co Ltd (002262) market capitalisation.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.59x | CN¥640.98 Million | CN¥1.08 Billion | CN¥437.41 Million | ▲ +16.8% |
| 2024 | 0.51x | CN¥466.07 Million | CN¥916.13 Million | CN¥450.06 Million | ▼ -19.1% |
| 2023 | 0.63x | CN¥634.31 Million | CN¥1.01 Billion | CN¥373.99 Million | ▲ +1.6% |
| 2022 | 0.62x | CN¥533.27 Million | CN¥861.02 Million | CN¥327.75 Million | ▼ -12.3% |
| 2021 | 0.71x | CN¥495.01 Million | CN¥701.12 Million | CN¥206.11 Million | ▼ -10.0% |
| 2020 | 0.78x | CN¥979.74 Million | CN¥1.25 Billion | CN¥268.61 Million | ▲ +64.8% |
| 2019 | 0.48x | CN¥145.67 Million | CN¥305.97 Million | CN¥160.30 Million | ▼ -17.6% |
| 2018 | 0.58x | CN¥233.83 Million | CN¥404.52 Million | CN¥170.70 Million | ▼ -8.7% |
| 2017 | 0.63x | CN¥286.34 Million | CN¥452.35 Million | CN¥166.01 Million | ▲ +0.3% |
| 2016 | 0.63x | CN¥174.92 Million | CN¥277.14 Million | CN¥102.22 Million | ▲ +1139.9% |
| 2015 | -0.06x | CN¥-12.40 Million | CN¥204.24 Million | CN¥216.63 Million | ▲ +90.4% |
| 2014 | -0.63x | CN¥-101.36 Million | CN¥160.24 Million | CN¥261.60 Million | ▼ -235.5% |
| 2013 | 0.47x | CN¥90.70 Million | CN¥194.33 Million | CN¥103.63 Million | ▼ -5.5% |
| 2012 | 0.49x | CN¥76.16 Million | CN¥154.16 Million | CN¥78.01 Million | ▲ +14.9% |
| 2011 | 0.43x | CN¥34.87 Million | CN¥81.08 Million | CN¥46.21 Million | ▲ +211.8% |
| 2010 | -0.38x | CN¥-23.78 Million | CN¥61.79 Million | CN¥85.57 Million | ▼ -223.3% |
| 2009 | 0.31x | CN¥19.12 Million | CN¥61.27 Million | CN¥42.15 Million | ▲ +59.5% |
| 2008 | 0.20x | CN¥9.10 Million | CN¥46.50 Million | CN¥37.40 Million | ▲ +44.2% |
| 2007 | 0.14x | CN¥6.59 Million | CN¥48.55 Million | CN¥41.96 Million | ▲ +182.4% |
| 2006 | -0.16x | CN¥-5.11 Million | CN¥30.99 Million | CN¥36.09 Million | ▲ +93.7% |
| 2005 | -2.62x | CN¥-23.15 Million | CN¥8.84 Million | CN¥31.99 Million | — |